Stock data

晉弘 (6796)

晉弘 is a TWSE-listed company in Biotech & Medical Care. Revenue for September 2026 was NT$67.59M, up 21.3% from a year earlier. EPS over the last four quarters totals NT$0.47.

Charts, drawing tools, and the P/E calculator are in the app, free to use.

Open 晉弘 in Insightr